SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Key result
SGLT2 inhibitors evaluated in a comprehensive meta-analysis of five randomized heart failure trials.
Authors
Discussion
Loading...
Member takes
Implication
Supports broad SGLT2 inhibitor use in heart failure; confirms consistent benefit across ejection fraction spectrum.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Vaduganathan et al. (2022) studied this question. SGLT2 inhibitors were evaluated in a comprehensive meta-analysis of five randomized controlled trials involving patients with heart failure.